Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice
- 5 April 2007
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 83B (2), 408-415
- https://doi.org/10.1002/jbm.b.30810
Abstract
Synthetic matrices have been used widely to repair and/or to replace biological tissues. However, there is relatively little information on the effect of different anatomical compartments on the host response to foreign implants. We have analyzed such responses to sponge implants in subcutaneous and in intraperitoneal sites in mice at days 3, 5, and 8 postimplantation by measuring inflammation, angiogenesis, and production of proangiogenic/inflammatory cytokines. The angiogenic response, assessed by hemoglobin content and by morphometric analysis of the number of vessels, was higher in intraperitoneal implants. Levels of vascular endothelial growth factor in intraperitoneal implants were 14-fold higher than in subcutaneous implants at day 3 and remained high for the next 5 days. Neutrophil accumulation as determined by myeloperoxidase activity was the same in both types of implants. Macrophage accumulation (N-acetylglucosaminidase activity) was also similar on days 3 and 8 in both implants. Levels of the chemokine CXCL2/KC were always higher, but those of CCL2/JE lower, in the intraperitoneal implant. These results demonstrate that the anatomical site of the implant markedly influenced the host response to synthetic matrices. Our results provide a greater understanding of factors affecting the biocompatibility of exogenous materials placed at different anatomical sites. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2007Keywords
This publication has 20 references indexed in Scilit:
- The effect of particulate material on the regulation of chemokine receptor expression in leukocytesBiomaterials, 2006
- Influence of the structure of new generation prostheses on shrinkage after implant in the abdominal wallJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2006
- The attraction of chemokines as a target for specific anti‐inflammatory therapyBritish Journal of Pharmacology, 2006
- Inflammatory cells during wound repair: the good, the bad and the uglyTrends in Cell Biology, 2005
- Murine Chemokine CXCL2/KC Is a Surrogate Marker for Angiogenic Activity in the Inflammatory Granulation TissueMicrocirculation, 2005
- Composite prostheses used to repair abdominal wall defects: Physical or chemical adhesion barriers?Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in miceLife Sciences, 2004
- Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO)British Journal of Pharmacology, 2004
- Peritoneal molecular environment, adhesion formation and clinical implicationFrontiers in Bioscience-Landmark, 2002
- Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blueBiochimica et Biophysica Acta (BBA) - General Subjects, 1986